There is no cure. Between 1995 and 2021, around $42bn was poured into more than 1,000 clinical trials. Yet only a handful of ...

In ‘Doctored’, Charles Piller, a science journalist, details how groupthink and dishonesty steered Alzheimer’s research off ...

while beta-amyloid buildup in the amygdala is associated with emotional disturbances such as anxiety and fear. Additionally, when both proteins are present, they amplify brain inflammation and ...

These results hint at yet another insidious effect of COVID, the researchers write, suggesting even mild or moderate cases might speed up biological processes promoting the accumulation of beta ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

This study adds to the growing evidence that Alzheimer’s disease may start long before traditional symptoms appear. The fact ...

The errant growth of this protein is responsible ... named donanemab, targets amyloid beta only at a later stage when it has clumped together to form plaques. It offers similar efficacy to ...

Exercise may positively influence the interactions between brain cells in the hippocampus, a brain region involved in ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

An international clinical trial aimed at preventing Alzheimer’s disease (AD) in young adults who are at risk of developing ...